1. Home
  2. MAIA vs RFIL Comparison

MAIA vs RFIL Comparison

Compare MAIA & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • RFIL
  • Stock Information
  • Founded
  • MAIA 2018
  • RFIL 1979
  • Country
  • MAIA United States
  • RFIL United States
  • Employees
  • MAIA N/A
  • RFIL N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • RFIL Electrical Products
  • Sector
  • MAIA Health Care
  • RFIL Technology
  • Exchange
  • MAIA Nasdaq
  • RFIL Nasdaq
  • Market Cap
  • MAIA 46.7M
  • RFIL 39.9M
  • IPO Year
  • MAIA 2022
  • RFIL N/A
  • Fundamental
  • Price
  • MAIA $2.15
  • RFIL $3.99
  • Analyst Decision
  • MAIA
  • RFIL Strong Buy
  • Analyst Count
  • MAIA 0
  • RFIL 1
  • Target Price
  • MAIA N/A
  • RFIL $4.50
  • AVG Volume (30 Days)
  • MAIA 79.7K
  • RFIL 27.6K
  • Earning Date
  • MAIA 05-13-2025
  • RFIL 06-12-2025
  • Dividend Yield
  • MAIA N/A
  • RFIL N/A
  • EPS Growth
  • MAIA N/A
  • RFIL N/A
  • EPS
  • MAIA N/A
  • RFIL N/A
  • Revenue
  • MAIA N/A
  • RFIL $70,599,000.00
  • Revenue This Year
  • MAIA N/A
  • RFIL $16.16
  • Revenue Next Year
  • MAIA N/A
  • RFIL $5.75
  • P/E Ratio
  • MAIA N/A
  • RFIL N/A
  • Revenue Growth
  • MAIA N/A
  • RFIL 4.93
  • 52 Week Low
  • MAIA $1.40
  • RFIL $2.86
  • 52 Week High
  • MAIA $5.99
  • RFIL $5.77
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 70.43
  • RFIL 42.30
  • Support Level
  • MAIA $1.51
  • RFIL $3.75
  • Resistance Level
  • MAIA $1.61
  • RFIL $3.99
  • Average True Range (ATR)
  • MAIA 0.12
  • RFIL 0.28
  • MACD
  • MAIA 0.06
  • RFIL -0.02
  • Stochastic Oscillator
  • MAIA 90.91
  • RFIL 34.65

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About RFIL RF Industries Ltd.

RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.

Share on Social Networks: